Delivery Order SPE2DB20D3303-SPE2DB25FA2ZW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,895.72 to AmerisourceBergen Drug Corp for INLYTA 5 mg tablets (60-count packaging) on September 11, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Inlyta 5 mg tablets (60-count units) with a ceiling value of $11,895.72. This non-set-aside contract, awarded on July 21, 2025, utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $11,895.72 to AmerisourceBergen Drug Corp for INLYTA 5 mg tablets (60 count) on August 12, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. INLYTA is a prescription pharmaceutical used in the treatment of certain cancers, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $11,923.60 to AmerisourceBergen Drug Corp for the supply of INLYTA 1 mg tablets (180-count units). This contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award selection. The delivery order is scheduled for completion by August 15, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INLYTA is a targeted cancer therapy...
- The Defense Logistics Agency awarded a $23.79K delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of INLYTA 5 MG tablets (60-count units). This firm fixed-price, non-competitive delivery order is scheduled for completion by October 16, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. As a child delivery order, this award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, for 180 tablets of Inlyta 1 mg on September 22, 2025, with a ceiling value of $23,847.20 and completion date of October 14, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global...
- The Defense Logistics Agency awarded a $23,791.44 delivery order to AmerisourceBergen Drug Corp for 60 tablets of INLYTA 5 mg on September 18, 2025, with an ultimate completion date of October 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a $23,791.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of INLYTA 5 mg tablets (60 count). The contract, which is non-set-aside and competitively awarded, designates Conshohocken, Pennsylvania as the place of performance and carries an ultimate completion date of October 20, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $11.9K to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Inlyta 5 mg tablets (60-count units). The contract is firm fixed price with an ultimate completion date of October 2, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across...
- The Defense Logistics Agency awarded a $11,895.72 delivery order to AmerisourceBergen Drug Corp for INLYTA 5 mg tablets (60-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2ZWDelivery Order
The Defense Logistics Agency awarded a $11.9K delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Inlyta 5 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Inlyta is a prescription medication used in oncology treatment, reflecting the federal government's ongoing pharmaceutical supply needs for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9M through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen has demonstrated consistent capability to meet competitive federal procurement requirements across multiple therapeutic domains through numerous delivery orders under this prime contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 8/26/25 |